University of Victoria biomedical engineer 'outsmarts' HIV

December 10, 2010

It is estimated that 38 million people worldwide are currently infected with HIV and that 4.1 million more are added each year. For scientists to design treatment therapies that are effective over the long-term it is essential to learn more about how the virus mutates and develops resistance to medications.

New, groundbreaking research by University of Victoria biomedical engineer Stephanie Willerth has significantly advanced the understanding of HIV and how to treat it.

"The mutates at a very high rate which is very problematic for because the virus eventually develops resistance to medications,'' explains Willerth, a faculty member with UVic's Department of Mechanical Engineering and the Division of Medical Sciences.

Willerth and her team studied approximately 15,000 different versions of the virus—something that has never been done before. This information has allowed them to locate the specific genes of the virus that were resistant to the drugs—knowledge that could ultimately help researchers develop more effective treatments for HIV.

Willerth says that the methods she used can be applied to other difficult-to-treat viruses such as swine flu, Ebola, influenza or even staph infections.

"To study all of these different versions we have to replicate them millions of times, especially when it comes to complex viruses like HIV," explains Willerth. "Because this research method requires a large amount of genetic material and there are obvious risks of duplicating highly contagious viruses, scientists have avoided doing this. Our research was unique because of the method we used—we isolated the genetic material from HIV, so that it was no longer alive, before we replicated it."

After replicating the virus from a small sample obtained from a long-term patient who had developed drug resistance to their treatment, Willerth and her team studied its genetic make-up using "next generation" DNA sequencing—a new method that allows researchers to study millions of molecules at a time.

More information: Willerth SM, Pedro HAM, Pachter L, Humeau LM, Arkin AP, et al. (2010) Development of a Low Bias Method for Characterizing Viral Populations Using Next Generation Sequencing Technology. PLoS ONE 5(10): e13564. doi:10.1371/journal.pone.0013564

Related Stories

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

6 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

nada
5 / 5 (8) Dec 10, 2010
Is it just me or does the title not match the story?

Still waiting for HOW they outsmarted HIV.
maxcypher
1.3 / 5 (3) Dec 10, 2010
This is how:
"This information has allowed them to locate the specific genes of the virus that were resistant to the drugs—knowledge that could ultimately help researchers develop more effective treatments for HIV."
nanolouizos
2 / 5 (3) Dec 10, 2010
I believe that they outsmarted the virus by finding a way to augment DNA replication of different strains without the need to replicate the whole virus.
lexington
5 / 5 (3) Dec 10, 2010
So rather than a cure we just have a slightly better idea of why a cure is just about impossible.
satyricon
5 / 5 (6) Dec 10, 2010
I loathe it when they try to make the titles 'fancy' to lure readers, like in tabloids.

Science articles, at least, should keep their titles simple and truthful and should never be misleading.
SkiSci
not rated yet Dec 11, 2010
I think this approach largely ignores epigenetic factors which may influence resistance. (I.E. Certain species of bacteria shift DNA expression once a certain threshold of bacteria density is crossed)

On another note, my lascivious, condom-loathing penis applauds this research.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.